vs
Bowman Consulting Group Ltd.（BWMN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Bowman Consulting Group Ltd.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.7倍（$129.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 13.9%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $8.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 16.6%）
SLR咨询是一家私有的国际可持续发展咨询企业，在欧洲、北美洲、南美洲、大洋洲及非洲均设有办事处。公司以「推动可持续发展落地」为宗旨，凭借遍布全球的专业顾问与技术团队，携手客户共同应对全球最复杂的各类可持续发展挑战。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BWMN vs PBYI — 直观对比
营收规模更大
BWMN
是对方的1.7倍
$75.5M
营收增速更快
PBYI
高出13.8%
13.9%
自由现金流更多
PBYI
多$6.2M
$8.1M
两年增速更快
PBYI
近两年复合增速
16.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $129.0M | $75.5M |
| 净利润 | $2.0M | — |
| 毛利率 | 55.0% | 69.3% |
| 营业利润率 | 3.2% | 22.7% |
| 净利率 | 1.5% | — |
| 营收同比 | 13.9% | 27.7% |
| 净利润同比 | -66.7% | — |
| 每股收益（稀释后） | $0.13 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BWMNPBYI
| Q4 25 | $129.0M | $75.5M | ||
| Q3 25 | $126.0M | $54.5M | ||
| Q2 25 | $122.1M | $52.4M | ||
| Q1 25 | $112.9M | $46.0M | ||
| Q4 24 | $113.2M | $59.1M | ||
| Q3 24 | $113.9M | $80.5M | ||
| Q2 24 | $104.5M | $47.1M | ||
| Q1 24 | $94.9M | $43.8M |
净利润BWMNPBYI
| Q4 25 | $2.0M | — | ||
| Q3 25 | $6.6M | $8.8M | ||
| Q2 25 | $6.0M | $5.9M | ||
| Q1 25 | $-1.7M | $3.0M | ||
| Q4 24 | $5.9M | — | ||
| Q3 24 | $771.0K | $20.3M | ||
| Q2 24 | $-2.1M | $-4.5M | ||
| Q1 24 | $-1.6M | $-4.8M |
毛利率BWMNPBYI
| Q4 25 | 55.0% | 69.3% | ||
| Q3 25 | 53.1% | 77.7% | ||
| Q2 25 | 53.7% | 76.5% | ||
| Q1 25 | 51.4% | 77.1% | ||
| Q4 24 | 53.2% | 76.4% | ||
| Q3 24 | 52.4% | 63.9% | ||
| Q2 24 | 52.5% | 77.4% | ||
| Q1 24 | 50.6% | 75.5% |
营业利润率BWMNPBYI
| Q4 25 | 3.2% | 22.7% | ||
| Q3 25 | 4.2% | 17.6% | ||
| Q2 25 | 7.4% | 12.7% | ||
| Q1 25 | 1.0% | 8.7% | ||
| Q4 24 | 1.2% | 22.6% | ||
| Q3 24 | 0.4% | 27.4% | ||
| Q2 24 | -1.2% | -4.6% | ||
| Q1 24 | -2.8% | -5.3% |
净利率BWMNPBYI
| Q4 25 | 1.5% | — | ||
| Q3 25 | 5.3% | 16.2% | ||
| Q2 25 | 4.9% | 11.2% | ||
| Q1 25 | -1.5% | 6.5% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 0.7% | 25.2% | ||
| Q2 24 | -2.0% | -9.6% | ||
| Q1 24 | -1.6% | -11.0% |
每股收益（稀释后）BWMNPBYI
| Q4 25 | $0.13 | $0.26 | ||
| Q3 25 | $0.37 | $0.17 | ||
| Q2 25 | $0.34 | $0.12 | ||
| Q1 25 | $-0.11 | $0.06 | ||
| Q4 24 | $0.37 | $0.40 | ||
| Q3 24 | $0.04 | $0.41 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.11 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.1M | $97.5M |
| 总债务越低越好 | $57.6M | $22.7M |
| 股东权益账面价值 | $261.1M | $130.3M |
| 总资产 | $579.7M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.22× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BWMNPBYI
| Q4 25 | $11.1M | $97.5M | ||
| Q3 25 | $16.2M | $94.4M | ||
| Q2 25 | $15.5M | $96.0M | ||
| Q1 25 | $10.7M | $93.2M | ||
| Q4 24 | $6.7M | $101.0M | ||
| Q3 24 | $11.7M | $96.7M | ||
| Q2 24 | $23.1M | $96.8M | ||
| Q1 24 | $11.7M | $107.2M |
总债务BWMNPBYI
| Q4 25 | $57.6M | $22.7M | ||
| Q3 25 | $29.8M | $34.0M | ||
| Q2 25 | $32.0M | $45.3M | ||
| Q1 25 | $36.4M | $56.7M | ||
| Q4 24 | $38.1M | $68.0M | ||
| Q3 24 | $36.4M | $79.3M | ||
| Q2 24 | $38.8M | $90.7M | ||
| Q1 24 | $26.8M | $102.0M |
股东权益BWMNPBYI
| Q4 25 | $261.1M | $130.3M | ||
| Q3 25 | $261.8M | $115.3M | ||
| Q2 25 | $249.6M | $104.7M | ||
| Q1 25 | $244.1M | $97.1M | ||
| Q4 24 | $246.1M | $92.1M | ||
| Q3 24 | $243.2M | $71.1M | ||
| Q2 24 | $235.6M | $48.5M | ||
| Q1 24 | $167.3M | $51.0M |
总资产BWMNPBYI
| Q4 25 | $579.7M | $216.3M | ||
| Q3 25 | $510.2M | $202.9M | ||
| Q2 25 | $538.2M | $194.9M | ||
| Q1 25 | $528.7M | $196.2M | ||
| Q4 24 | $505.9M | $213.3M | ||
| Q3 24 | $497.0M | $220.7M | ||
| Q2 24 | $463.4M | $205.0M | ||
| Q1 24 | $420.5M | $214.1M |
负债/权益比BWMNPBYI
| Q4 25 | 0.22× | 0.17× | ||
| Q3 25 | 0.11× | 0.30× | ||
| Q2 25 | 0.13× | 0.43× | ||
| Q1 25 | 0.15× | 0.58× | ||
| Q4 24 | 0.15× | 0.74× | ||
| Q3 24 | 0.15× | 1.12× | ||
| Q2 24 | 0.16× | 1.87× | ||
| Q1 24 | 0.16× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 6.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.9% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.76× | — |
| 过去12个月自由现金流最近4个季度 | $33.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BWMNPBYI
| Q4 25 | $9.4M | $14.4M | ||
| Q3 25 | $10.2M | $9.7M | ||
| Q2 25 | $4.3M | $14.1M | ||
| Q1 25 | $12.0M | $3.6M | ||
| Q4 24 | $11.9M | $15.6M | ||
| Q3 24 | $6.8M | $11.0M | ||
| Q2 24 | $3.1M | $1.0M | ||
| Q1 24 | $2.5M | $11.2M |
自由现金流BWMNPBYI
| Q4 25 | $8.1M | $14.4M | ||
| Q3 25 | $10.1M | $9.7M | ||
| Q2 25 | $4.2M | $14.1M | ||
| Q1 25 | $11.0M | $3.6M | ||
| Q4 24 | $11.7M | $15.6M | ||
| Q3 24 | $6.6M | $11.0M | ||
| Q2 24 | $2.7M | $1.0M | ||
| Q1 24 | $2.3M | — |
自由现金流率BWMNPBYI
| Q4 25 | 6.3% | 19.1% | ||
| Q3 25 | 8.0% | 17.7% | ||
| Q2 25 | 3.4% | 26.8% | ||
| Q1 25 | 9.7% | 7.7% | ||
| Q4 24 | 10.4% | 26.4% | ||
| Q3 24 | 5.8% | 13.7% | ||
| Q2 24 | 2.6% | 2.1% | ||
| Q1 24 | 2.4% | — |
资本支出强度BWMNPBYI
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.9% | 0.1% | ||
| Q4 24 | 0.2% | 0.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 0.3% | 0.0% |
现金转化率BWMNPBYI
| Q4 25 | 4.76× | — | ||
| Q3 25 | 1.54× | 1.10× | ||
| Q2 25 | 0.71× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 2.02× | — | ||
| Q3 24 | 8.81× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
